C12N 2760/18842
Virus or viral particle as vehicle
Official title: virus or viral particle as vehicle, e.g. encapsulating small organic molecule
C12N2760/18842 (Virus or viral particle as vehicle) appears on 3 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 7
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 4 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Polynucleotide for modifying target sequence and use thereof4 Feb 2025US 12,215,334 B2I'rom Group Co., Ltd.
- Methods for making, compositions comprising, and methods of using rejuvenated T cells17 Sep 2024US 12,091,682 B2Lyell Immunopharma, Inc.
- Composition having antitumor effect18 Jan 2011US 7,871,765 B2AnGesMG, Inc.
- Methods for Making, Compositions Comprising, and Methods of Using Rejuvenated T Cells15 May 2025US 2025/0154458 A1Lyell Immunopharma, Inc.
- Methods for making, compositions comprising, and methods of using rejuvenated t cells26 May 2022US 2022/0162551 A1Lyell Immunopharma, Inc.
- Polynucleotide for modifying target sequence and use thereof9 Jul 2020US 2020/0216858 A1I'rom Group Co., Ltd.
- Method for Producing Induced Pluripotent Stem Cells20 Oct 2016US 2016/0304840 A1New England Biolabs, Inc.
- Drug delivery vehicle for cancer therapy, process for producing the same, and pharmaceutical preparation using the same3 Nov 2011US 2011/0268769 A1
Most cited
By later US patents